Naoum FA. Iron deficiency in cancer patients. rev bras hematol hemoter. 2016;38(4):325-30.Naoum FA. Iron deficiency in cancer patients. Rev Bras Hematol Hemoter. 2016;38(4):325-330.Iron deficiency in cancer patients. Naoum FA. Rev Bras Hematol Hemoter . 2016...
ChT, chemotherapy; ESA, erythropoiesis-stimulating agent; Hb, haemoglobin; ID, iron deficiency; i.v., intravenous; RBC, red blood cell; RT, radiotherapy; TSAT, transferrin saturation. Table 2. Managing anaemia in patients with MDS When should ESA treatment be considered?a Treatment of anaemia ...
摘要: e18751Background: Iron deficiency anemia (IDA) is a common condition in cancer patients (pts) and can have a deleterious effect on their outcomes. Pts with hepatocellular carcinoma (HCC) often have...DOI: 10.1200/JCO.2018.36.15_suppl.e18751 年份: 2018 ...
This online, on-demand virtual symposium brings together renowned experts in hematology and oncology to discuss the latest data concerning iron-deficiency anemia in cancer patients. To help clinicians deliver quality patient care and improve patient outcomes, these ex...
The recent discovery of hepcidin (the master regulator of iron metabolism) has shed new light on the regulation of iron homeostasis and has helped our understanding of complex clinical situations, such as those observed in critically ill patients, where several regulatory circuits interfere with iron...
CANCER patientsIRON deficiencyIRON compoundsAim: We aimed to find the optimal route of iron supplementation in patients with malignancy and iron deficiency (true or functional) anemia not receiving erythropoiesis stimulating agents (ESA). Methods: Adult patients with malignancy requiring chemothera...
Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. Ann Oncol. 2018;29(suppl 4):iv96-iv110. doi:10.1093/annonc/mdx758 PubMedGoogle ScholarCrossref 5. Mikhail A, Brown C, Williams JA, et al. Renal association clinical ...
Overall transfused patients were significantly older (mean 73 years old vs. 53 years old; P < 0·0001) with more comorbidities than those not trans... DE Grey,J Finlayson - 《Vox Sanguinis》 被引量: 27发表: 2010年 Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer ...
Iron deficiency (ID) and anaemia are frequent complications in cancer patients, in particular during treatment with chemotherapeutic agents [1., 2., 3.]. ID, even in the absence of anaemia, may be associated with impaired physical function, weakness, and fatigue that can be ameliorated by iro...
Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia Only limited data on the prevalence of iron deficiency (ID) and its correlation with clinical parameters are available in cancer. ID frequently contributes... H Ludwig,E ...